Streetbeat News

Earnings

GENC

Gencor Industries (NASDAQ:GENC) reported a decrease in Q3 earnings per share (EPS) to $0.17 from $0.22 year-over-year, and a decline in sales to $25.55 million from $27.88 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:42 pm

ZVSA

ZyVersa Therapeutics (NASDAQ:ZVSA) reported a Q2 EPS of $(3.31), beating the analyst consensus estimate of $(3.75) by 11.73%. This represents a significant improvement over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:40 pm

BORR

Borr Drilling announced preliminary Q2 revenue of $272 million, surpassing the estimated $250.5 million.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:34 pm

BRT

BRT Apartments (NYSE:BRT) reported Q2 earnings of $0.35 per share, beating the analyst estimate of $0.28. Sales were $23.86 million, also surpassing the $23.60 million estimate. Despite the earnings beat, EPS decreased by 5.41% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:32 pm

BLTE

Belite Bio (NASDAQ:BLTE) reported a Q2 2024 GAAP EPS of $(0.26), missing the analyst consensus estimate of $(0.25) by 4%.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:31 pm

DJT

Trump Media & Technology (NASDAQ:DJT) reported Q2 EPS of $(0.10), an improvement from $(0.26) YoY, but sales decreased by 29.80% to $836.90K from $1.19M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:26 pm

EDSA

Edesa Biotech (NASDAQ:EDSA) reported a Q3 2024 GAAP EPS of $(0.52), beating the analyst consensus estimate of $(0.58) by 10.34%.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:24 pm

MSGM

Motorsport Games shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:23 pm

REVB

Revelation Biosciences (NASDAQ:REVB) reported a Q2 2024 GAAP EPS loss of $(5.13) per share.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:22 pm

CDRE

Cadre has updated its FY24 revenue guidance to $571M-$582M, slightly above the previous estimate of $569.94M, following a cyber incident in July 2024. The company has contained the incident and is resuming operations. Adjusted EBITDA is expected to be $103M-$109M, with capital expenditures of $7M-$9M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 8:21 pm